Nuclear Newswire
  • Topics
    • Advanced Reactors
    • Advocacy
    • Conferences
    • Decontamination & Decommissioning
    • Education
    • Environmental Remediation
    • Fuel
    • Fusion
    • Industry
    • International
    • Isotopes & Radiation
    • Nonproliferation
    • Nuclear History
    • People
    • Policy
    • Power & Operations
    • Research & Applications
    • Security
    • Standards
    • Supply Chain
    • Transportation
    • Waste Management
    • Webinars
    • Workforce
  • Sources
    • Nuclear News
    • Radwaste Solutions
    • ANS News
    • ANS Nuclear Cafe
    • Sponsored Content
    • Press Releases
  • Sign Up
  • Buyers Guide
    • Access Online Buyers Guide
    • Manage/Create Company Listings
    • Advertise in Buyers Guides
  • Advertise
  • ANS
Headlines For You
  • Valar’s Ward 250 reaches criticality in Utah
    June 22, 2026, 10:44AM
  • Elementl plans Ohio nuclear plant; Oklo, Centrus sign Ohio-centered LOI
    June 22, 2026, 7:10AM
  • Two steps forward for U.K. advanced nuclear
    June 18, 2026, 3:47PM
  • A message from Matrix Business Concepts LLC
    From Plan to Reality: Closing the Execution Gap in Nuclear Projects
  • A flurry of nuclear developments in Sweden—state aid, SMR selections, legislation
    June 18, 2026, 12:20PM
  • Zeno pursues nuclear battery manufacturing at Vallecitos
    June 18, 2026, 9:33AM
  • NSTX-U magnet bundle is delivered to PPPL and prepared for installation
    June 18, 2026, 7:29AM
  • Oklo signs MOU with Standard Nuclear to explore plutonium recycling
    June 17, 2026, 3:53PM
  • For personalized headlines, please log in/create an account.
Latest Issue — Jun 2026
Latest Issue — Jan 2026

Newswire

Tag: fusion pharmaceuticals

HSB Global Inspection and Engineering Services – We provide specialized inspection and certification services for boilers, pressure vessels, nuclear components, and power plants worldwide. Wherever your business takes you, we’re at your side. Global reach. Local presence.

Learn More

Isotopes & Radiation

BWXT to supply Ac-225 generation to Fusion Pharmaceuticals

November 20, 2023, 7:00AMNuclear News

BWX Technologies subsidiary BWXT Medical has agreed to provide Fusion Pharmaceuticals with generators to produce actinium-225, a medical isotope used to treat cancer in clinical trials.

LinkedInTwitterFacebookEmail
To continue reading, log in or create a free account!
Tags:
ac-225bwxt medicalfusion pharmaceuticalsmedical isotopesradioisotopes
Share:
Receive Nuclear News Daily
Join ANS Today
Donate Today
Trustees of Nuclear
Amentum
AMS
Clearpath
Constellation
Core Power
Dominion Engineering
Fissionaire
Global Laser Enrichment
Hogan Lovells
Lightbridge
Mirion Technologies
Nuscale
Oklo
Orrick
Paragon
Radiant
Southern Nuclear
Studsvik
TerraPower
Urenco
X-Energy
American Nuclear Society

Advancing nuclear science and technology for the benefit of humanity

  • Advertising Opportunities
  • Navigating Nuclear
  • Contact Us
  • FacebookFacebook
  • TwitterTwitter
  • LinkedInLinkedIn
  • InstagramInstagram
  • YouTubeYouTube
  • PinterestPinterest
  • Nuclear NewswireNuclear Newswire
  • Email ListsEmail Lists

© Copyright 2026 American Nuclear Society

  • Privacy Policy
  • Terms of Use
  • Invoices
  • Media